| 0.2 |
1.5 |
GO:0003172 |
primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.2 |
0.6 |
GO:2000724 |
nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.2 |
0.8 |
GO:0002399 |
MHC class II protein complex assembly(GO:0002399) |
| 0.1 |
0.4 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.1 |
0.4 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.4 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) divalent metal ion export(GO:0070839) |
| 0.1 |
0.3 |
GO:0006714 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.1 |
0.4 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 |
0.4 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.6 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
0.4 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.5 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 |
1.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.1 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.1 |
0.6 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
0.2 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 |
1.2 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.4 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.3 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.3 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.0 |
0.2 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.0 |
0.3 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 |
0.3 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.1 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.2 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.2 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.0 |
0.1 |
GO:0050787 |
antibiotic metabolic process(GO:0016999) detoxification of mercury ion(GO:0050787) |
| 0.0 |
0.2 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.0 |
0.2 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 |
0.4 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.2 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.0 |
0.2 |
GO:0006480 |
N-terminal protein amino acid methylation(GO:0006480) |
| 0.0 |
0.1 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 |
0.2 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 |
0.5 |
GO:1903944 |
regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.0 |
0.1 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.0 |
0.1 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.0 |
0.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 |
0.2 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.0 |
0.2 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.0 |
0.2 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.0 |
0.1 |
GO:2000502 |
negative regulation of lymphocyte chemotaxis(GO:1901624) negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.0 |
0.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.2 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.0 |
0.2 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.7 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.3 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.2 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.1 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.0 |
0.3 |
GO:1902748 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 |
0.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.3 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.0 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.0 |
0.2 |
GO:0031179 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.0 |
0.1 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.0 |
0.2 |
GO:0003402 |
planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.0 |
0.1 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.0 |
0.1 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 |
0.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.0 |
0.2 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.0 |
0.1 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.0 |
0.1 |
GO:0002545 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.0 |
0.1 |
GO:0044179 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.0 |
0.1 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 |
0.1 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.0 |
0.3 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.1 |
GO:1902567 |
astrocyte chemotaxis(GO:0035700) negative regulation of eosinophil activation(GO:1902567) positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 0.0 |
0.1 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.0 |
0.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.7 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.0 |
0.1 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.1 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 |
0.2 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.0 |
0.1 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.2 |
GO:1905097 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.0 |
0.1 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.0 |
0.2 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.1 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.0 |
0.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.0 |
0.1 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.0 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.0 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 |
1.6 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 |
0.1 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.0 |
0.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.0 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.0 |
0.3 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.1 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.0 |
0.0 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.0 |
0.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.0 |
0.1 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.0 |
0.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.0 |
0.0 |
GO:1904404 |
cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.0 |
0.1 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.0 |
0.1 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.1 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 |
0.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.1 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.2 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.0 |
0.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
0.1 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.0 |
0.0 |
GO:1990619 |
histone H3-K9 deacetylation(GO:1990619) |
| 0.0 |
0.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.0 |
GO:1903280 |
negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 0.0 |
0.2 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.0 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 |
0.2 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.0 |
0.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.0 |
GO:0042713 |
positive regulation of norepinephrine secretion(GO:0010701) response to anoxia(GO:0034059) sperm ejaculation(GO:0042713) |
| 0.0 |
0.1 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 |
0.0 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.0 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.0 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.0 |
0.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.3 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.1 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.0 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.0 |
0.4 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 |
0.0 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.0 |
0.1 |
GO:0019216 |
regulation of lipid metabolic process(GO:0019216) |
| 0.0 |
0.0 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.0 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.0 |
0.0 |
GO:0007439 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.0 |
0.1 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.1 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.1 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.0 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.2 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
